title: A multi-center study in order to further define the molecular basis of beta-thalassemia in Thailand, Pakistan, Sri Lanka, Mauritius, Syria, and India, and to develop a simple molecular diagnostic strategy by amplification refractory mutation system-polymerase chain reaction.
abstract: The spectrum of the beta-thalassemia mutations of Thailand, Pakistan, India, Sri Lanka, Mauritius and Syria has been further characterized by a multi-center study of 1,235 transfusion-dependent patients, and the mutations discovered used to assess the fidelity of a simple diagnostic strategy. A total of 44 beta-thalassemia mutations were identified either by allele-specific oligonucleotide hybridization, amplification with allele-specific primers, or DNA sequencing of amplified product. The results confirm and extend earlier findings for Thailand, Pakistan, India, Mauritius and Syria. This is the first detailed report of the spectrum of mutations for Sri Lanka. Two novel mutations were identified, codon 55 (-A) and IVS-I-129 (A-->C), both found in Sri Lankan patients. Two beta-thalassemia mutations were found to coexist in one beta-globin gene: Sri Lankan patients homozygous for the beta0 codon 16 (-C) frameshift were also homozygous for the beta+ codon 10 (C-->A) mutation. Studies of Sri Lankan, Pakistani, and Indian carriers suggest the codon 10 (C-->A) mutation is just a rare polymorphism on an ancestral allele, on which the beta0 codon 16 (-C) mutation has arisen. Each country was found to have only a few common mutations accounting for 70% or more of the beta-thalassemia alleles. A panel of primers to diagnose the majority of the mutations by the amplification refractory mutation system was developed, enabling a simple molecular diagnostic strategy to be introduced for each country participating in the multi-center study.
authors.affiliation: National Haemoglobinopathy Reference Laboratory, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, UK. JOld@hammer.imm.ox.ac.uk
authors.forename: J M
authors.initials: JM
authors.lastname: Old
authors.forename: S N
authors.initials: SN
authors.lastname: Khan
authors.forename: I
authors.initials: I
authors.lastname: Verma
authors.forename: S
authors.initials: S
authors.lastname: Fucharoen
authors.forename: M
authors.initials: M
authors.lastname: Kleanthous
authors.forename: P
authors.initials: P
authors.lastname: Ioannou
authors.forename: N
authors.initials: N
authors.lastname: Kotea
authors.forename: C
authors.initials: C
authors.lastname: Fisher
authors.forename: S
authors.initials: S
authors.lastname: Riazuddin
authors.forename: R
authors.initials: R
authors.lastname: Saxena
authors.forename: P
authors.initials: P
authors.lastname: Winichagoon
authors.forename: K
authors.initials: K
authors.lastname: Kyriacou
authors.forename: F
authors.initials: F
authors.lastname: Al-Quobaili
authors.forename: B
authors.initials: B
authors.lastname: Khan
mesh_terms: D001208:Asia / Q000453:epidemiology; D001483:Base Sequence; D004252:DNA Mutational Analysis / Q000379:methods; D017931:DNA Primers; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D007391:International Cooperation; D009154:Mutation; D016133:Polymerase Chain Reaction / Q000379:methods; D017086:beta-Thalassemia / Q000453:epidemiology / Q000235:genetics*
chemical_list: D017931:DNA Primers